Literature DB >> 1716913

Metal affinity chromatography of recombinant HIV-1 reverse transcriptase containing a human renin cleavable metal binding domain.

S K Sharma1, D B Evans, A F Vosters, T J McQuade, W G Tarpley.   

Abstract

A metal binding peptide, hexahistidine, preceding a renin cleavage sequence (Pro-Phe-His-Leu-Val-Ile-His-) was engineered on to the N-terminus of HIV-1 reverse transcriptase (RT). The chimeric protein was expressed in Escherichia coli and characterized after purification by DEAE chromatography and HPLC. Amino-terminal sequencing confirmed the presence of the first 15 amino acids of the chimeric protein. The chimeric exhibited RT activity like that of HIV-1 RT and was cleaved by human renin at the expected site. The potential of a hexa-histidine fusion in the purification of recombinant HIV-1 RT by immobilized metal affinity chromatography (IMAC) on the commonly used resin (IDA-Ni2+) was investigated. The chimeric gene product from a crude E. coli extract was strongly retarded on a immobilized nickel column, while most of the contaminating E. coli proteins were eliminated after elution with 20-35 mM imidazole. The bound chimeric protein was eluted with 300 mM imidazole and appeared predominantly as a single band on an SDS-polyacrylamide gel. The remarkable specificity of this affinity tail was further demonstrated by separating the chimeric protein from HIV-1 RT in a crude extract prepared by mixing extracts from cells expressing HIV-1 RT and the hexahistidine recombinant chimeric protein. The usefulness of a enzymatically cleavable metal binding peptide in the rapid purification and production of HIV-1 RT without proteolysis to a heterodimer is discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1716913

Source DB:  PubMed          Journal:  Biotechnol Appl Biochem        ISSN: 0885-4513            Impact factor:   2.431


  10 in total

1.  A mutation in reverse transcriptase of bis(heteroaryl)piperazine-resistant human immunodeficiency virus type 1 that confers increased sensitivity to other nonnucleoside inhibitors.

Authors:  T J Dueweke; T Pushkarskaya; S M Poppe; S M Swaney; J Q Zhao; I S Chen; M Stevenson; W G Tarpley
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-15       Impact factor: 11.205

2.  U-90152, a potent inhibitor of human immunodeficiency virus type 1 replication.

Authors:  T J Dueweke; S M Poppe; D L Romero; S M Swaney; A G So; K M Downey; I W Althaus; F Reusser; M Busso; L Resnick
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

3.  (Alkylamino) piperidine bis(heteroaryl)piperizine analogs are potent, broad-spectrum nonnucleoside reverse transcriptase inhibitors of drug-resistant isolates of human immunodeficiency virus type 1 (HIV-1) and select for drug-resistant variants of HIV-1IIIB with reduced replication phenotypes.

Authors:  R A Olmsted; D E Slade; L A Kopta; S M Poppe; T J Poel; S W Newport; K B Rank; C Biles; R A Morge; T J Dueweke; Y Yagi; D L Romero; R C Thomas; S K Sharma; W G Tarpley
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

4.  Production and characterization of recombinant human Ku antigen.

Authors:  M Ono; P W Tucker; J D Capra
Journal:  Nucleic Acids Res       Date:  1994-09-25       Impact factor: 16.971

Review 5.  Galectin-1: a bifunctional regulator of cellular proliferation.

Authors:  Ken Scott; Cristina Weinberg
Journal:  Glycoconj J       Date:  2002       Impact factor: 2.916

6.  Partial identification by site-directed mutagenesis of a cell growth inhibitory site on the human galectin-1 molecule.

Authors:  Ken Scott; Jialiang Zhang
Journal:  BMC Cell Biol       Date:  2002-01-25       Impact factor: 4.241

7.  Eukaryotic expression system Pichia pastoris affects the lipase catalytic properties: a monolayer study.

Authors:  Madiha Bou Ali; Yassine Ben Ali; Imen Aissa; Youssef Gargouri
Journal:  PLoS One       Date:  2014-08-18       Impact factor: 3.240

Review 8.  SUMO fusion technology for difficult-to-express proteins.

Authors:  Tauseef R Butt; Suzanne C Edavettal; John P Hall; Michael R Mattern
Journal:  Protein Expr Purif       Date:  2005-04-09       Impact factor: 1.650

Review 9.  Purification of viral polymerases: general considerations.

Authors:  V Sardana; M Sardana
Journal:  Methods Enzymol       Date:  1996       Impact factor: 1.600

10.  Specific and efficient cleavage of fusion proteins by recombinant plum pox virus NIa protease.

Authors:  Nuoyan Zheng; José de Jesús Pérez; Zhonghui Zhang; Elvira Domínguez; Juan Antonio Garcia; Qi Xie
Journal:  Protein Expr Purif       Date:  2007-10-22       Impact factor: 1.650

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.